ENDOMETRIAL ADENOCARCINOMA
Clinical trials for ENDOMETRIAL ADENOCARCINOMA explained in plain language.
Never miss a new study
Get alerted when new ENDOMETRIAL ADENOCARCINOMA trials appear
Sign up with your email to follow new studies for ENDOMETRIAL ADENOCARCINOMA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New drug combo tested in battle against Tough-to-Treat gynecologic cancers
Disease control OngoingThis early-stage study is testing a combination of two drugs, niraparib (a pill) and copanlisib (an IV infusion), for women whose ovarian, endometrial, or related cancers have returned after prior treatment. The main goals are to find the safest dose of this combination and to le…
Matched conditions: ENDOMETRIAL ADENOCARCINOMA
Phase: PHASE1 • Sponsor: M.D. Anderson Cancer Center • Aim: Disease control
Last updated Apr 01, 2026 14:42 UTC
-
New drug duo aims to fight tough uterine cancer
Disease control OngoingThis study is testing whether a new combination of two drugs, cadonilimab and lenvatinib, can help control advanced endometrial cancer that has continued to grow after standard chemotherapy. It will involve about 32 patients to see how well the combination shrinks tumors and how …
Matched conditions: ENDOMETRIAL ADENOCARCINOMA
Phase: PHASE2 • Sponsor: Sun Yat-sen University • Aim: Disease control
Last updated Apr 01, 2026 14:41 UTC
-
New hope for Tough-to-Treat uterine cancer: trial tests multiple drug combos
Disease control OngoingThis study is testing several drug combinations to see which works best for women with advanced endometrial cancer that has returned or stopped responding to treatment. It compares single drugs against combinations to see which can better control the cancer and keep it from growi…
Matched conditions: ENDOMETRIAL ADENOCARCINOMA
Phase: PHASE2 • Sponsor: National Cancer Institute (NCI) • Aim: Disease control
Last updated Mar 30, 2026 14:35 UTC
-
New drug combo tested for Tough-to-Treat uterine cancer
Disease control OngoingThis study is testing whether adding an experimental drug (BMS-986205) to an existing immunotherapy (nivolumab) works better for controlling recurrent endometrial cancer. It is for women whose cancer has come back after initial platinum-based chemotherapy. The main goal is to see…
Matched conditions: ENDOMETRIAL ADENOCARCINOMA
Phase: PHASE2 • Sponsor: Memorial Sloan Kettering Cancer Center • Aim: Disease control
Last updated Mar 30, 2026 14:32 UTC
-
Three-Way drug fight against advanced uterine cancer
Disease control OngoingThis study aims to find the most effective drug combination for controlling advanced or recurrent endometrial cancer. It enrolled 349 patients to test three different mixes of chemotherapy and targeted therapy drugs. The goal is to see which combination best slows cancer growth a…
Matched conditions: ENDOMETRIAL ADENOCARCINOMA
Phase: PHASE2 • Sponsor: National Cancer Institute (NCI) • Aim: Disease control
Last updated Mar 23, 2026 15:19 UTC
-
Scientists test new pill cocktails in fight against tough cancers
Disease control OngoingThis early-stage trial is testing the safety and best doses of two different combinations of oral medications for people with recurrent endometrial, ovarian, or triple-negative breast cancer. The study combines an existing drug (olaparib) with one of two newer drugs (AZD2014 or A…
Matched conditions: ENDOMETRIAL ADENOCARCINOMA
Phase: PHASE1 • Sponsor: M.D. Anderson Cancer Center • Aim: Disease control
Last updated Mar 23, 2026 15:18 UTC